Bone-Boosting combo could help women with osteoporosis
NCT ID NCT04467983
First seen Jun 09, 2026 · Last updated Jun 14, 2026 · Updated 1 time
Summary
This study looks at whether adding abaloparatide to the usual denosumab treatment can improve bone density more than denosumab alone in postmenopausal women with osteoporosis. About 70 women who have already had at least four denosumab shots will take part. The goal is to see if the combination leads to stronger bones at the hip and spine after 18 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTMENOPAUSAL OSTEOPOROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital for Special Surgery
New York, New York, 10021, United States
Conditions
Explore the condition pages connected to this study.
Conditions inferred from the trial description
These were inferred from the trial's summary, not listed by the trial registrant.